D016754

2 trials

Sponsors

Miyatake Shin-ichi, Shiba Shintaro

Conditions

Tumor Tumorrecurrent high-grade meningioma (WHO grade 2 or 3) high-grade meningioma

Phase 2

Investigator-lead clinical trial of accelerator-based BNCT for high-grade meninigioma

Active, not recruitingJPRN-jRCT2051190044

Miyatake Shin-ichirecurrent high-grade meningioma (WHO grade 2 or 3) high-grade meningioma

Start: 2019-09-04Target: 18Updated: 2026-06-29

BNCT for Unresectable FBPA-PET-Positive Tumors

RecruitingJPRN-jRCTs031250713

Shiba ShintaroTumor Tumor

Start: 2026-03-16Target: 50Updated: 2026-06-29